Literature DB >> 20398645

Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes.

Sandhya Narasimhan1, Kuppan Gokulakrishnan, Rangasamy Sampathkumar, Syed Farooq, Radhakrishnan Ravikumar, Viswanathan Mohan, Muthuswamy Balasubramanyam.   

Abstract

OBJECTIVE: Our work is aimed at exploring the interrelationship of oxidative stress and insulin resistance in NAFLD subjects with and without type 2 diabetes in a population-based study.
METHODS: Subjects [n=200] were recruited from the Chennai Urban Rural Epidemiology Study. 1: Normal glucose tolerance (NGT) subjects without NAFLD; 2: NGT with NAFLD; 3: type 2 diabetic subjects [T2DM] without NAFLD and 4: T2DM with NAFLD. Thiobarbituric acid reactive substances (TBARS), protein carbonyl (PCC) and glutathione levels were measured by standard methods. Ultrasound of the liver was used to diagnose NAFLD.
RESULTS: TBARS and PCC levels were significantly elevated and GSH/GSSG ratio was significantly decreased in diabetic subjects with NAFLD compared to all other groups (p trend <0.001). Oxidative stress markers significantly associated with NAFLD even after adjusting for age, gender, BMI and glycemic status.
CONCLUSIONS: Increased oxidative stress is independently associated with NAFLD in Asian Indians without and with T2DM. Copyright 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20398645     DOI: 10.1016/j.clinbiochem.2010.04.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  42 in total

1.  Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.

Authors:  Nicola Santoro; Sonia Caprio; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2013-08-01

2.  Ellagic acid attenuates high-carbohydrate, high-fat diet-induced metabolic syndrome in rats.

Authors:  Sunil K Panchal; Leigh Ward; Lindsay Brown
Journal:  Eur J Nutr       Date:  2012-04-27       Impact factor: 5.614

Review 3.  The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Authors:  Mithun Sharma; Shasikala Mitnala; Ravi K Vishnubhotla; Rathin Mukherjee; Duvvur N Reddy; Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2015-02-16

4.  Nonalcoholic Fatty Liver Disease and Diabetes Are Associated with Decreased CYP3A4 Protein Expression and Activity in Human Liver.

Authors:  Rohitash Jamwal; Suzanne M de la Monte; Ken Ogasawara; Sravani Adusumalli; Benjamin B Barlock; Fatemeh Akhlaghi
Journal:  Mol Pharm       Date:  2018-06-11       Impact factor: 4.939

Review 5.  Reprint of: Nutrition in the Management of Cirrhosis and its Neurological Complications.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2015-02-19

Review 6.  Modern approach to the clinical management of non-alcoholic fatty liver disease.

Authors:  Maria Del Ben; Licia Polimeni; Francesco Baratta; Daniele Pastori; Lorenzo Loffredo; Francesco Angelico
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

7.  Pitfalls in the analysis of the physiological antioxidant glutathione (GSH) and its disulfide (GSSG) in biological samples: An elephant in the room.

Authors:  Daniela Giustarini; Dimitrios Tsikas; Graziano Colombo; Aldo Milzani; Isabella Dalle-Donne; Paolo Fanti; Ranieri Rossi
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-02-12       Impact factor: 3.205

8.  Patients with Nonalcoholic Fatty Liver Disease (NAFLD) have Higher Oxidative Stress in Comparison to Chronic Viral Hepatitis.

Authors:  Amit Kumar; Arun Sharma; Ajay Duseja; Ashim Das; Radha K Dhiman; Yogesh K Chawla; Krishan K Kohli; Anil Bhansali
Journal:  J Clin Exp Hepatol       Date:  2012-11-02

Review 9.  Nutrition in the management of cirrhosis and its neurological complications.

Authors:  Chantal Bémeur; Roger F Butterworth
Journal:  J Clin Exp Hepatol       Date:  2013-06-11

10.  Effects of the SGLT2 inhibitor ipragliflozin on various diabetic symptoms and progression of overt nephropathy in type 2 diabetic mice.

Authors:  Atsuo Tahara; Toshiyuki Takasu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-01-26       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.